Nanoday-2022-Agenda.pdf

Nanoday-2022-Agenda.pdf

AlzPED: Raising the standards for preclinical testing of Alzheimer’s drug candidates | National Institute on Aging

AlzPED: Raising the standards for preclinical testing of Alzheimer’s drug candidates | National Institute on Aging

Activity Lowers Risk of Death | Cachexia | Genetics of Cancer, 08/30/2022

Activity Lowers Risk of Death | Cachexia | Genetics of Cancer, 08/30/2022

FDA Approves First Treatment for Acid Sphingomyelinase Deficiency, a Rare Genetic Disease | FDA

FDA Approves First Treatment for Acid Sphingomyelinase Deficiency, a Rare Genetic Disease | FDA

First U.S. patient receives autologous stem cell therapy to treat dry AMD | National Institutes of Health (NIH)

First U.S. patient receives autologous stem cell therapy to treat dry AMD | National Institutes of Health (NIH)

Multiple sclerosis may be partially caused by a virus. Could a vaccine be the solution? - Genetic Literacy Project

Multiple sclerosis may be partially caused by a virus. Could a vaccine be the solution? - Genetic Literacy Project

Clinical Trials Update from NCI, August 2022

Clinical Trials Update from NCI, August 2022